Activity-mediated plasticity of GABA equilibrium potential in rat hippocampal CA1 neurons

Exp Neurol. 2010 Jan;221(1):157-65. doi: 10.1016/j.expneurol.2009.10.017. Epub 2009 Oct 29.

Abstract

The equilibrium potential (E(GABA)(-PSC)) for gamma-aminobutyric acid (GABA) A receptor mediated inhibitory postsynaptic currents (PSCs) in hippocampal CA1 pyramidal neurons shifts when theta-burst stimulation (four pulses at 100 Hz in each burst in a train consisting of five bursts with an inter-burst interval of 200 ms, the train repeated thrice at 30-s intervals) is applied to the input. E(GABA)(-PSC) is regulated by K(+)/Cl(-) co-transporter (KCC2). GABA(B) receptors are implicated in modulating KCC2 levels. In the current study, the involvement of KCC2, as well as GABA(B) receptors, in theta-burst-mediated shifts in E(GABA)(-PSC) was examined. Whole-cell patch recordings were made from hippocampal CA1 pyramidal neurons (from 9 to 12 days old rats), in a slice preparation. Glutamatergic excitatory postsynaptic currents were blocked with dl-2-amino-5-phosphonovaleric acid (50 microM) and 6,7-dinitroquinoxaline-2,3-dione (20 microM). The PSC and the E(GABA)(-PSC) were stable when stimulated at 0.05 Hz. However, both changed following a 30-min stimulation at 0.5 or 1 Hz. Furosemide (500 microM) and KCC2 anti-sense in the recording pipette but not bumetanide (20 or 100 microM) or KCC2 sense, blocked the changes, suggesting KCC2 involvement. Theta-burst stimulation induced a negative shift in E(GABA)(-PSC), which was prevented by KCC2 anti-sense; however, KCC2 sense had no effect. CGP55845 (2 microM), a GABA(B) antagonist, applied in the superfusing medium, or GDP-beta-S in the recording pipette, blocked the shift in E(GABA)(-PSC). These results indicate that activity-mediated plasticity in E(GABA)(-PSC) occurs in hippocampal CA1 pyramidal neurons and theta-burst-induced negative shift in E(GABA)(-PSC) requires KCC2, GABA(B) receptors and G-protein activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology*
  • Animals
  • Animals, Newborn
  • Biophysics
  • Bumetanide / pharmacology
  • CA1 Region, Hippocampal / cytology*
  • Dose-Response Relationship, Drug
  • Electric Stimulation / methods
  • Furosemide / pharmacology
  • GABA Antagonists / pharmacology
  • Guanosine 5'-O-(3-Thiotriphosphate) / pharmacology
  • In Vitro Techniques
  • Male
  • Neuronal Plasticity / drug effects
  • Neuronal Plasticity / physiology*
  • Neurons / drug effects
  • Neurons / physiology*
  • Phosphinic Acids / pharmacology
  • Propanolamines / pharmacology
  • Rats
  • Rats, Wistar
  • Sodium Potassium Chloride Symporter Inhibitors / pharmacology
  • gamma-Aminobutyric Acid / metabolism*

Substances

  • GABA Antagonists
  • Phosphinic Acids
  • Propanolamines
  • Sodium Potassium Chloride Symporter Inhibitors
  • Bumetanide
  • CGP 55845A
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • gamma-Aminobutyric Acid
  • Furosemide